Published Medical Literature

Prognostic and Therapeutic Potential of CD73 Expression in Colorectal Cancer Liver Metastasis

Prognostic Model Based on Autophagy-Related Genes for Liver Cancer: An Asian Perspective

Phase IIa Trial Focuses on Second-Line Trifluridine Plus Tipiracil and Irinotecan in Advanced Liver Cancer

Potential of Novel Nanoparticle Treatment With Radiotherapy for Hepatocellular Carcinoma

Using M7G-Linked Long Noncoding RNAs to Predict Outcomes in Hepatocellular Carcinoma

Could Tumor Mutation Be Linked to Lenvatinib Resistance in Hepatocellular Carcinoma?

Does Type 2 Diabetes in People With NAFLD Increase the Risk of Hepatic Decompensation and Liver Cancer?

Could the Enzyme ACSL4 Be a Prognostic Marker in Cholangiocarcinoma?

Is Laparoscopic Surgery a Safe Option for Patients With Perihilar Cholangiocarcinoma?

Can Machine Learning Help to Improve Clinical Outcomes in Hepatocellular Carcinoma?

Is the Presence of Cirrhosis an Independent Prognostic Factor in Cholangiocarcinoma?

Reduction in Lipid Metabolism via miR-3180 Activity in Hepatocellular Carcinoma

Advanced Biliary Tract Cancer: Benefits Seen With Pembrolizumab Plus Chemotherapy in KEYNOTE-966

Does Adjuvant TACE Improve Outcomes After Hepatectomy for Hepatocellular Carcinoma?

Dual Inhibition of CDK4/6 and PI3K Under Study in Intrahepatic Cholangiocarcinoma

Hepatocellular Cancer Survival Rates: Disparity Reported Between Those Born In and Out of the United States

Researchers Find Stress Effector ATF4 May Suppress Hepatocarcinogenesis

Clinical Practice Guidelines for Managing Hepatocellular Carcinoma: An Asian Perspective

Clinical Use of Contrast-Enhanced Ultrasound in Diagnosing Hepatocellular Carcinoma

Could Plant Extract Be a Future Treatment of Liver Cancer?

Can ChatGPT Personalize Patient Education in Those With Cirrhosis and Liver Cancer?

Predicting Early Recurrence of Hepatocellular Carcinoma Using Multivariable Nomogram

Functionalized Nanomaterials and TACE Therapy for Hepatocellular Carcinoma

Dual Targeted Therapy and Immunotherapy in Unresectable Resistant Liver Cancer

Combination Therapy With Tyrosine Kinase and PD-1 Inhibitors in Unresectable Liver Cancer

How Lenvatinib Compares With Other Therapies for Nonviral, Unresectable Liver Cancer

Role of Circadian Clock Protein Regulation in the Proliferation of Liver Cancer

New Program Aims to Narrow Education Gap Among Patients With Cholangiocarcinoma

Nivolumab After Selective Internal Radiotherapy for Locally Advanced Liver Cancer

Evaluating the Role of BNIP3 in Hepatocellular Carcinoma Development and Progression

After a Diagnosis of Cholangiocarcinoma: Benefit of Well-Balanced Diet and Exercise

Researchers Find Certain Amino Acids May Be Potential Biomarkers of Hepatocellular Carcinoma

Targeted Agent Under Study in Treatment of Rare Liver Cancer

Is Gallbladder Cancer Overdiagnosed in Regions With a High Incidence?

Robotic Versus Open Liver Resection for Hepatocellular Carcinoma

Is IMRT Before Surgery of Benefit in Patients With Centrally Located Liver Cancer?

Triplet Combination Therapy Under Study in High-Risk Advanced Liver Cancer

Perihilar Cholangiocarcinoma: Preoperative Risk Factors for Early Recurrence

Dynamic Role of Hepatic Stellate Cell Subpopulations During Hepatocarcinogenesis

Novel Therapy Using Nanoparticles Under Study in Hepatocellular Carcinoma

Extracellular Vesicle–Based Protein Assay May Enable Earlier Detection of Hepatocellular Carcinoma

Does Exposure to Certain Industrial Chemicals Increase the Risk for Liver Cancer?

Atypical Growth Factor Induction of Circular Dorsal Ruffles in Hepatocellular Carcinoma Cells

Can Biomarkers Predict Outcomes With Nivolumab in Refractory Biliary Tract Cancer?

Rare Case of Liver Cancer With Neuroendocrine Differentiation: Focus on Use of Tumor Organoids

Systemic Immune Inflammation Index: Prognostic Tool in Extrahepatic Cholangiocarcinoma?

Identifying Risk Factors for Early Death in Patients With Advanced Hepatocellular Carcinoma

Machine Learning Applications in Gallbladder Cancer Prognosis

Impact of Chorion-Derived Mesenchymal Stem Cells on the Growth of Cholangiocarcinoma

Adding Durvalumab to Standard-of-Care Chemotherapy for Advanced Biliary Tract Cancer

Reserarch Reveals Prognostic Potential of Four Pyroptosis-Related Genes in Hepatocellular Carcinoma

Preclinical Data Point to GCN2 Inhibition as a Potential Treatment Strategy in Hepatocellular Carcinoma

Novel Nomogram May Help to Predict Cancer Risk and Survival Among Some Patients With Liver Cancer

Consider the Intestinal Environment in Predicting Immunotherapy Response in Liver Cancer

Can Kinome Profiling Influence Treatment Decisions for Patients With Cholangiocarcinoma?